Skip to main content
Intermediate Technical IVT

androgen deprivation therapy

Also written as: ADT — androgen deprivation therapy

Hormonal treatment that reduces or blocks testosterone production to slow prostate cancer growth.

Full Definition

Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced prostate cancer that works by reducing or eliminating testosterone and other male hormones that fuel cancer cell growth. The therapy can be achieved through surgical castration (orchiectomy) or medical castration using LHRH agonists or antagonists. ADT is often combined with other treatments and may be used in neoadjuvant, concurrent, or adjuvant settings. Side effects include hot flashes, osteoporosis, cardiovascular risks, and sexual dysfunction.

Usage

Usage note: Always spell out on first use, then use ADT abbreviation. Note hyphenation in full term.

In Context

  • "The patient began androgen deprivation therapy with leuprolide injections every three months." — Treatment protocol
  • "Long-term androgen deprivation therapy requires monitoring for bone density loss and cardiovascular complications." — Clinical guidance

Also known as

ADT hormone therapy chemical castration

Contrasted with

testosterone supplementation

Don't confuse with

antiandrogen therapy testosterone replacement therapy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON